AI Predicts Asymptomatic Carriers of COVID-19

Machine learning identifies superspreaders and ranks source of infection among a moving crowd

2 min read
People wearing face masks visit Chunxi Road, the busiest commercial pedestrian Street in Chengdu, China, on November 28, 2020.
Photo: Gao Han/VCG/Getty Images

One of COVID-19’s nastiest tricks is the way it can infect someone and not cause any symptoms. This allows the virus to proliferate under the radar of contact tracers. But new artificial intelligence could help track down these silent carriers. 

In a paper published Friday in the journal Scientific Reports, researchers at Synergies Intelligent Systems and Universität Hamburg describe a machine learning algorithm that can identify people in a moving crowd who are most likely asymptomatic carriers of the virus that causes COVID-19. The algorithm makes these predictions based on the GPS-tracked movement of people in a city environment, and known cases of infection. 

Such precision contact tracing could reduce the number of people needlessly quarantined by lockdowns and conventional contact tracing, according to the authors of the paper. “With this type of technology, we can quarantine a very small fraction of people—just three to five percent—and pretty effectively reduce the effect of the disease,” says Michael Chang, co-founder of Synergies.

The tool could also be used to identify superspreaders: people infected with the virus who transmit it to a disproportionately high number of people. This could aid public health leaders in prioritizing where to concentrate vaccine supplies to head off an outbreak, Chang says.  

One limitation of the tool is that its accuracy depends on people willingly using a GPS-based app on their phones. Such an app would track their location to an accuracy of one meter, and log any positive COVID-19 test results. 

“The mobile data is also collectible from cellular data,” says Jianwei Zhang, a professor at Universität Hamburg and an author of the paper. “If we could use data other than GPS to build interactive relations between people—for example by using cameras or indoor localization methods—this would boost the [algorithm’s] prediction accuracy.”

A number of researchers developed digital contact tracing apps early on in the pandemic. Such software was used extensively in East Asia, drawing criticism over privacy rights of citizens. The technology was not widely adopted in many other regions of the world. 

The new machine learning technology boosts the accuracy of digital contact tracing by factoring in asymptomatic transmission. The authors call their system “continuous learning and inference of individual probability” or CLIIP. It’s based on a gradient boost ensemble learning tree model. The model is updated with real world data using individual directed graph, or IDG, which is the direction for recording the interactions between individuals at a certain time. 

The algorithm also integrates real world data such as credit card transactions, public transport data, and building cameras to determine how long and how often people came into contact, and how much physical distance was between themThe real world data came from a city in China that the authors would not disclose.

The algorithm can also factor in mask wearing, hand washing and health. “Such information can be given by a user via an interactive interface or automatically extracted using further sensors,” says Zhang. “This would make the CLIIP predictions more precise.”  

The system labels people based on their disease status, such as susceptible, quarantined, exposed, infected, hospitalized and recovered. “By using these labels, we are using our interactive model to learn what would happen between one guy and his surroundings,” says Shangching Liu, an AI engineer at Synergies who co-authored the paper. Synergies Intelligent Systems is an AI company that builds augmented analytics technologies that decrease the barriers to AI.

The Conversation (0)

A New Treatment for Arthritis: Vagus-Nerve Stimulation

Studies will soon show whether electroceuticals outperform pharmaceuticals

5 min read
A tablet computer, a smartphone, a grey belt with white stripes, a grey disc, and a small silver rectangle with a wire curled beside it.

Galvani’s system includes a nerve stimulator that attaches to the splenic nerve.

Galvani Bioelectronics

Monique Robroek once had such crippling arthritis that, even with the best available medications, she struggled to walk across a room. But thanks to an electronic implant fitted under her skin, she managed to wean herself off all her drugs and live pain-free for nearly a decade—until recently, when a viral illness made her rheumatoid arthritis (RA) flare up again.

This article is part of our special report Top Tech 2023.

Robroek’s long remission is “very impressive” and rare among patients with RA, says her doctor Frieda Koopman, a rheumatologist at Amsterdam UMC, in the Netherlands. Robroek’s experience highlights the immense potential of so-called bioelectronic medicine, also known as electroceuticals, an emerging field of treatment for diseases that have traditionally been managed with pharmaceuticals alone.

Keep Reading ↓Show less